We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 1 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 5 actions collected · 0 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2024. 07. 16. | Janney Montgomery Scott | — | Initiate coverage | — → Buy | — | Janney Montgomery Scott: Buy |
| 2023. 11. 20. | Piper Sandler | — | Downgrade | Neutral → Underweight | — | Piper Sandler: Neutral → Underweight |
| 2023. 02. 13. | Piper Sandler | — | Downgrade | Overweight → Neutral | — | Piper Sandler: Overweight → Neutral |
| 2022. 05. 16. | Piper Sandler | — | Maintain | — → Overweight | — | Piper Sandler: Overweight |
| 2021. 11. 13. | Boenning & Scattergood | — | Downgrade | Outperform → Neutral | — | Boenning & Scattergood: Outperform → Neutral |
Past rating changes by firm, agreement/divergence within the sector, and what target changes mean.